13F Filings History of INVERNESS COUNSEL LLC /NY/

Latest 13F report
Q3 2022 - 26 Oct 2022
Value $
$1,798,417,000
Signature - Title
Philip S Lawrence - President
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by INVERNESS COUNSEL LLC /NY/. Form 13F is required to be filed within 45 days of the end of a calendar quarter. INVERNESS COUNSEL LLC /NY/ reported 186 stock holdings with total value $1,798,417,000 as of Q3 2022. Top holdings included ROP, CSL, DOV, MSFT, and AAPL.

Notify me when INVERNESS COUNSEL LLC /NY/ files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q3 2022 186 $1,798,417,000 +$270,118,323 -$109,472,732 +$160,645,591 ROP, CSL, DOV, MSFT, AAPL 13F-HR 26 Oct 2022, 09:49
Q2 2022 169 $1,782,232,000 +$145,403,236 -$172,988,570 -$27,585,334 ROP, CSL, DOV, MSFT, AAPL 13F-HR 19 Jul 2022, 18:40
Q1 2022 189 $2,232,634,000 +$260,623,991 -$489,603,260 -$228,979,269 ROP, DOV, CSL, MSFT, AAPL 13F-HR 05 May 2022, 12:55
Q4 2021 190 $2,712,653,000 +$239,638,736 -$582,268,974 -$342,630,238 ROP, DOV, MSFT, CSL, AMZN 13F-HR 07 Feb 2022, 14:15
Q3 2021 178 $2,721,985,000 +$216,843,959 -$204,885,324 +$11,958,635 ROP, DOV, AMZN, MSFT, CSL 13F-HR 02 Nov 2021, 12:37
Q2 2021 176 $2,743,958,000 +$338,869,502 -$274,268,408 +$64,601,094 ROP, DOV, MSFT, CSL, AAPL 13F-HR 10 Aug 2021, 13:45
Q1 2021 153 $2,420,313,000 +$269,808,862 -$361,982,397 -$92,173,535 ROP, DOV, CSL, MSFT, AAPL 13F-HR 04 May 2021, 10:49
Q4 2020 145 $2,447,615,000 +$162,293,569 -$164,252,178 -$1,958,609 ROP, DOV, CSL, AMZN, ADBE 13F-HR 27 Jan 2021, 11:52
Q3 2020 134 $2,237,472,000 +$289,003,578 -$205,228,676 +$83,774,902 ROP, DOV, ADBE, AMZN, MSFT 13F-HR 03 Nov 2020, 09:14
Q2 2020 125 $2,008,712,000 +$240,854,682 -$131,370,856 +$109,483,826 ROP, DOV, CSL, MSFT, ADBE 13F-HR 10 Aug 2020, 11:50
Q1 2020 117 $1,593,318,000 +$227,438,227 -$424,715,241 -$197,277,014 ROP, DOV, CSL, MSFT, ADBE 13F-HR 05 May 2020, 10:31
Q4 2019 129 $2,116,909,000 +$252,907,802 -$214,828,701 +$38,079,101 ROP, DOV, CSL, MSFT, ADBE 13F-HR 05 Feb 2020, 16:40
Q3 2019 118 $1,932,851,000 +$140,017,362 -$170,405,203 -$30,387,841 ROP, CSL, MSFT, DOV, ADBE 13F-HR 12 Nov 2019, 16:57
Q2 2019 117 $1,957,464,000 +$157,817,518 -$159,297,017 -$1,479,499 ROP, CSL, DOV, MSFT, ADBE 13F-HR 07 Aug 2019, 17:10
Q1 2019 117 $1,835,532,000 +$201,480,092 -$128,811,659 +$72,668,433 ROP, CSL, DOV, MSFT, ADBE 13F-HR 08 May 2019, 18:19
Q4 2018 117 $1,493,213,000 +$169,805,139 -$297,086,714 -$127,281,575 ROP, CSL, MSFT, DOV, ADBE 13F-HR 29 Jan 2019, 16:14
Q3 2018 132 $1,900,043,000 +$139,839,312 -$137,910,450 +$1,928,862 ROP, CSL, MSFT, DOV, ADBE 13F-HR 30 Oct 2018, 14:45
Q2 2018 133 $1,758,761,000 +$238,422,136 -$181,054,759 +$57,367,377 ROP, CSL, MSFT, DOV, ADBE 13F-HR 02 Aug 2018, 17:00
Q1 2018 146 $1,661,854,000 +$275,410,721 -$196,940,023 +$78,470,698 ROP, CSL, DOV, MSFT, ADBE 13F-HR 02 May 2018, 16:59
Q4 2017 100 $1,593,544,000 +$204,983,597 -$119,744,988 +$85,238,609 ROP, CSL, DOV, MSFT, UNH 13F-HR 01 Feb 2018, 19:33
Q3 2017 98 $1,415,926,000 +$122,590,797 -$217,808,935 -$95,218,138 ROP, CSL, DOV, MSFT, UNH 13F-HR 17 Oct 2017, 11:32
Q2 2017 92 $1,440,398,000 +$105,734,229 -$138,631,587 -$32,897,358 ROP, DOV, CSL, MSFT, UNH 13F-HR 26 Jul 2017, 10:09
Q1 2017 94 $1,435,870,000 +$170,860,379 -$94,950,732 +$75,909,647 ROP, DOV, CSL, ADBE, MSFT 13F-HR 13 Apr 2017, 11:23
Q4 2016 92 $1,312,761,000 +$200,335,975 -$201,500,242 -$1,164,267 ROP, CSL, DOV, MSFT, ADBE 13F-HR 02 Feb 2017, 10:23
Q3 2016 88 $1,271,170,000 +$107,214,184 -$175,578,040 -$68,363,856 ROP, CSL, DOV, META, ADBE 13F-HR 07 Nov 2016, 14:23
Q2 2016 94 $1,286,903,000 +$114,686,025 -$106,637,029 +$8,048,996 ROP, CSL, DOV, GE, META 13F-HR 04 Aug 2016, 09:59
Q1 2016 92 $1,289,102,000 +$105,010,546 -$133,790,589 -$28,780,043 ROP, CSL, DOV, META, GE 13F-HR 11 May 2016, 15:59
Q4 2015 104 $1,320,992,000 +$138,735,437 -$92,648,269 +$46,087,168 ROP, CSL, DOV, META, DIS 13F-HR 04 Feb 2016, 10:38
Q3 2015 108 $1,182,057,000 +$91,080,418 -$146,661,462 -$55,581,044 ROP, CSL, DOV, DIS, CAVM 13F-HR 22 Oct 2015, 11:58
Q2 2015 108 $1,378,844,000 +$145,648,963 -$145,672,144 -$23,181 ROP, CSL, DOV, MYL, CAVM 13F-HR 16 Jul 2015, 12:42
Q1 2015 113 $1,358,327,000 +$231,604,309 -$201,301,682 +$30,302,627 ROP, CSL, DOV, CAVM, MYL 13F-HR 14 Apr 2015, 11:29
Q4 2014 117 $1,301,902,000 +$128,343,994 -$115,829,788 +$12,514,206 ROP, CSL, DOV, CAVM, ADBE 13F-HR 20 Jan 2015, 09:39
Q3 2014 118 $1,248,430,000 +$72,772,628 -$89,563,477 -$16,790,849 ROP, CSL, DOV, GILD, ADBE 13F-HR 15 Oct 2014, 09:43
Q2 2014 120 $1,280,973,000 +$117,075,401 -$115,022,645 +$2,052,756 ROP, CSL, DOV, ADBE, PNC 13F-HR 17 Jul 2014, 09:30
Q1 2014 112 $1,258,121,000 +$134,216,236 -$127,972,568 +$6,243,668 ROP, CSL, DOV, GOOGL, PNC 13F-HR 15 Apr 2014, 12:06
Q4 2013 118 $1,258,018,000 $0 $0 $0 ROP, DOV, CSL, GILD, GOOGL 13F-HR 17 Jan 2014, 12:41